Adicet Bio, Inc.
ACET
|
$1.95
-3.7%
-3.85%
730K
|
Health Technology
(0.0% 1d) (-4.4% 1m) (-68.4% 1y) (0.0% 2d) (-14.1% 3d) (-11.4% 7d) (-4.34% volume)
Earnings Calendar: 2024-03-13
Market Cap: $ 160,230,726
http://www.adicetbio.com
Sec Filling | Patents | 18 employees
(US) Adicet Bio, Inc. is a biotechnology company which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
cancer t-cell ceiling
add to watch list Paper trade email alert is off
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10